
Biomerica fell 42.4% from $2.29 to $1.32, behind the S&P 500's +11.2%. Its worst day was Nov 12 (−12.6%), and its low came Nov 12 at $1.32.
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
CMS is the single largest payer for healthcare in the United States, with Medicare responsible for approximately 21% of total healthcare expenditure.The $300 rate will apply to claims approved and paid by Medicare with
+12.4% · S&P 500 +0.5%
Story events cover the past 12 months · Times ET
EPS of $-0.45 was reported on $1.2M revenue.
−1.1% · S&P 500 +0.3%
Biomerica shares rose 11.5%, while the S&P 500 rose 0.9%.
+11.5% · S&P 500 +0.9%
EPS of $-0.44 was reported on $987,000.00 revenue.
+1.0% · S&P 500 +1.2%
Biomerica shares fell 9.1%, while the S&P 500 rose 1.0%.
−9.1% · S&P 500 +1.0%
EPS of $-0.38 was reported on $875,000.00 revenue.
0.0% · S&P 500 −0.7%
Biomerica shares rose 9.4%, while the S&P 500 fell 0.0%.
+9.4% · S&P 500 0.0%
EPS of $-0.37 was reported on $1.3M revenue.
+5.0% · S&P 500 −1.1%
Where it ended: a close of $1.32 on Nov 16, 2026. Up next: Q2 2027 earnings on Jan 13, 2027.
Nothing in the past 12 months.
All BMRA analyst actionsNothing in the past 12 months.
All BMRA dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BMRA and SPY from Benzinga historical bars. Not investment advice.